09 December 2019 2 Min Read
Sanofi buys Synthorx for $2.5bn
Acquisition at triple market value accelerates French drug maker's push into cancer drugs under new CEO
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In